First published 10/2/2026, 5:13:15 AM · Last updated 10/2/2026, 5:13:15 AM

Strategy to achieve biomarker-driven immunosuppression after solid organ transplantation by an academic-industry partnership within the European BIO-DrIM consortium

Journal article presenting a strategy to use biomarkers to guide immunosuppression after solid organ transplantation developed through an academic–industry partnership within the European BIO-DrIM consortium. Publisher listed as Bio-Byword Scientific Publishing and published 2016-03-17; content type: journal article.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 6/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 6/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 4/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 4/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 7/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The work aims to advance biomarker-guided immunosuppression strategies for transplant patients.

Sources

Strategy to achieve biomarker-driven immunosuppression after solid organ transplantation by an academic-industry partnership within the European BIO-DrIM consortium

Report an issue